DnB Asset Management
MBOT icon

DnB Asset Management’s Microbot Medical MBOT Stock Holding History

DnB Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.63M Hold
677,498
– – 0.01% 604
2025
Q4 		$1.35M Buy
677,498
+433,869
+178% +$1.03M ﹤0.01% 622
2025
Q3 		$743K Buy
243,629
+50,843
+26% +$159K ﹤0.01% 649
2025
Q2 		$486K Buy
192,786
+77,965
+68% +$187K ﹤0.01% 651
2025
Q1 		$173K Buy
+114,821
New +$203K ﹤0.01% 707

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DnB Asset Management's MBOT Position: Q1 2026 in Review

DnB Asset Management held its Microbot Medical (MBOT) position steady in Q1 2026 at 677,498 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #604.

DnB Asset Management first reported a position in MBOT in Q1 2025 and has held it in 5 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • DnB Asset Management held 677,498 shares of Microbot Medical worth $1.63M as of Q1 2026.
  • DnB Asset Management left its Microbot Medical share count unchanged in Q1 2026.
  • Microbot Medical made up 0.01% of DnB Asset Management's portfolio in Q1 2026, its #604 holding.
  • DnB Asset Management first reported a position in Microbot Medical in Q1 2025 and has held it in 5 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.